Showing results (91-100 of 160) with videos related to
Sort By:
Pageof 16
The New England Journal of Medicine|February 8, 2002
Expression of p53 and prognosis in children with malignant gliomasIan F Pollack, Sydney D Finkelstein, Jeffrey Woods, et al.Pediatric Blood & Cancer|November 30, 2020
Brain biomarkers and neuropsychological outcomes of pediatric posterior fossa brain tumor survivors treated with surgical resection with or without adjuvant chemotherapyMary C Baron Nelson, Sharon H O'Neil, Jeffrey Tanedo, et al.Neuroradiology|November 13, 2017
T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot studyGiovanni Morana, Cesar Augusto Alves, Domenico Tortora, et al.Journal of Neurosurgery. Pediatrics|December 20, 2015
The influence of central review on outcome in malignant gliomas of the spinal cord: the CCG-945 experienceEric Bouffet, Jeffrey C Allen, James M Boyett, et al.Neuro-Oncology|December 1, 2012
Management of children with brain tumors in ParaguayJacquelyn L Baskin, Eva Lezcano, Bo Sung Kim, et al.Pediatric Blood & Cancer|March 12, 2014
A retrospective analysis of recurrent intracranial ependymomaReuben Antony, Kenneth E Wong, Moneil Patel, et al.Pediatric Blood & Cancer|November 12, 2021
Epidemiological characteristics and survival outcomes of children with medulloblastoma treated at the National Cancer Institute (INCA) in Rio de Janeiro, BrazilGabriela Oigman, Diana S Osorio, Sima Ferman, et al.Journal of Neuro-Oncology|February 11, 2018
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumorsNathan J Robison, Kee Kiat Yeo, Adrian P Berliner, et al.Pediatric Blood & Cancer|September 17, 2013
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology GroupVandana Batra, Stephen A Sands, Emi Holmes, et al.Journal of Pediatric Hematology/Oncology|November 25, 2020
Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 PatientsRichard T Graham, Erica H Bell, Amy Webb, et al.Pageof 16